New hope for tough leukemia cases: tracking Real-World results

NCT ID NCT06092879

Ongoing Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study observes how well adults with chronic myeloid leukemia stay on Scemblix treatment after trying at least two other therapies. It follows 201 patients in France for 15 months to see if they remain on the medication and how their disease responds. The goal is to understand how this treatment works in everyday clinic settings outside of controlled trials.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Novartis Investigative Site

Angers, France, 49933, France
Novartis Investigative Site

Challes-les-Eaux, France, 73190, France
Novartis Investigative Site

Limoges, Haute Vienne, 87000, France
Novartis Investigative Site

Saint Priest Jarez, Pays de la Loire Region, 42270, France
Novartis Investigative Site

Aix-en-Provence, 13616, France
Novartis Investigative Site

Amiens, 80054, France
Novartis Investigative Site

Antibes, 06600, France
Novartis Investigative Site

Avignon, 84000, France
Novartis Investigative Site

Besançon, 25030, France
Novartis Investigative Site

Bobigny, 93009, France
Novartis Investigative Site

Bordeaux, 33000, France
Novartis Investigative Site

Bordeaux, 33076, France
Novartis Investigative Site

Brest, 29609, France
Novartis Investigative Site

Brive-la-Gaillarde, 19100, France
Novartis Investigative Site

Caen, 14033, France
Novartis Investigative Site

Cagnes-sur-Mer, 06800, France
Novartis Investigative Site

Cannes, 06414, France
Novartis Investigative Site

Castelnau-le-Lez, 34170, France
Novartis Investigative Site

Cesson-Sévigné, 35576, France
Novartis Investigative Site

Chambéry, 73000, France
Novartis Investigative Site

Clermont-Ferrand, 63003, France
Novartis Investigative Site

Corbeil-Essonnes, 91100, France
Novartis Investigative Site

Dunkirk, 59240, France
Novartis Investigative Site

Essey-lès-Nancy, 54270, France
Novartis Investigative Site

Grenoble, 38043, France
Novartis Investigative Site

Le Kremlin-Bicêtre, 94275, France
Novartis Investigative Site

Le Mans, 72000, France
Novartis Investigative Site

Lens, 62307, France
Novartis Investigative Site

Libourne, 33505, France
Novartis Investigative Site

Lorient, 56100, France
Novartis Investigative Site

Lyon, 69373, France
Novartis Investigative Site

Montpellier, 34070, France
Novartis Investigative Site

Montpellier, 34295, France
Novartis Investigative Site

Mulhouse, 68070, France
Novartis Investigative Site

Nantes, 44277, France
Novartis Investigative Site

Nevers, 58000, France
Novartis Investigative Site

Nice, 06105, France
Novartis Investigative Site

Nîmes, 30029, France
Novartis Investigative Site

Orléans, 45100, France
Novartis Investigative Site

Paris, 75013, France
Novartis Investigative Site

Paris, 75015, France
Novartis Investigative Site

Paris, 75475, France
Novartis Investigative Site

Perpignan, 66046, France
Novartis Investigative Site

Périgueux, 24019, France
Novartis Investigative Site

Pierre-Bénite, 69495, France
Novartis Investigative Site

Poitiers, 86021, France
Novartis Investigative Site

Quimper, 29000, France
Novartis Investigative Site

Rennes, 35033, France
Novartis Investigative Site

Roubaix, 59100, France
Novartis Investigative Site

St-Malo, 35403, France
Novartis Investigative Site

Strasbourg, 67085, France
Novartis Investigative Site

Tarbes, 65100, France
Novartis Investigative Site

Toulouse, 31059, France
Novartis Investigative Site

Tours, 37044, France
Novartis Investigative Site

Trévenans, 90400, France
Novartis Investigative Site

Troyes, 10003, France
Novartis Investigative Site

Valence, 26953, France
Novartis Investigative Site

Vandœuvre-lès-Nancy, 54511, France
Novartis Investigative Site

Vesoul, 70014, France

Conditions

Explore the condition pages connected to this study.

CHRONIC MYELOID LEUKEMIA